Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 432

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Open access
Ingles, Jodie, Goldstein, Jennifer, Thaxton, Courtney, Caleshu, Colleen, Corty, Edward W., Crowley, Stephanie B., Dougherty, Kristen, Harrison, Steven M., McGlaughon, Jennifer, Milko, Laura V., Morales, Ana, Seifert, Bryce A., Strande, Natasha, Thomson, Kate, Peter van Tintelen, J., Wallace, Kathleen, Walsh, Roddy, Wells, Quinn, Whiffin, Nicola, Witkowski, Leora, Semsarian, Christopher, Ware, James S., Hershberger, Ray E., Funke, Birgit·2019·Circulation: Genomic and Precision Medicine

Abstract

Background: Genetic testing for families with hypertrophic cardiomyopathy (HCM) provides a significant opportunity to improve care. Recent trends to increase gene panel sizes often mean variants in genes with questionable association are reported to patients. Classification of HCM genes and variants is critical, as misclassification can lead to genetic misdiagnosis. We show the validity of previously reported HCM genes using an established method for evaluating gene-disease associations. Methods: A systematic approach was used to assess the validity of reported gene-disease associations, including associations with isolated HCM and syndromes including left ventricular hypertrophy. Genes were categorized as having definitive, strong, moderate, limited, or no evidence of disease causation. We also reviewed current variant classifications for HCM in ClinVar, a publicly available variant resource. Results: Fifty-seven genes were selected for curation based on their frequent inclusion in HCM testing and prior association reports. Of 33 HCM genes, only 8 (24%) were categorized as definitive ( MYBPC3 , MYH7 , TNNT2 , TNNI3 , TPM1 , ACTC1 , MYL2 , and MYL3 ); 3 had moderate evidence ( CSRP3, TNNC1 , and JPH2 ; 33%); and 22 (66%) had limited (n=16) or no evidence (n=6). There were 12 of 24 syndromic genes definitively associated with isolated left ventricular hypertrophy. Of 4191 HCM variants in ClinVar, 31% were in genes with limited or no evidence of disease association. Conclusions: The majority of genes previously reported as causative of HCM and commonly included in diagnostic tests have limited or no evidence of disease association. Systematically curated HCM genes are essential to guide appropriate reporting of variants and ensure the best possible outcomes for HCM families.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circgen.119.002460

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 432

Metadata

Authors
Ingles, J., Goldstein, J., Thaxton, C., Caleshu, C., Corty, E. W., Crowley, S. B., Dougherty, K., Harrison, S. M., McGlaughon, J., Milko, L. V., Morales, A., Seifert, B. A., Strande, N., Thomson, K., Peter van Tintelen, J., Wallace, K., Walsh, R., Wells, Q., Whiffin, N., Witkowski, L., Semsarian, C., Ware, J. S., Hershberger, R. E., & Funke, B.
Venue
Circulation: Genomic and Precision Medicine
Published
2019-02
Volume
12
Issue
2
Pages
e002460-e002460
ISSN
2574-8300 (ISSN-L)
OpenAlex
W2911299823
Cited by
432
References
33
FWCI
29.99
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. https://app.cochat.ai/papers/10.1161/circgen.119.002460
The paper
Ingles, J., Goldstein, J., Thaxton, C., Caleshu, C., Corty, E. W., Crowley, S. B., Dougherty, K., Harrison, S. M., McGlaughon, J., Milko, L. V., Morales, A., Seifert, B. A., Strande, N., Thomson, K., Peter van Tintelen, J., Wallace, K., Walsh, R., Wells, Q., Whiffin, N., . . . Funke, B. (2019). Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.119.002460

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.